- Home
- PCRX vs CYH Comparison
PCRX vs CYH Comparison
Compare PCRX & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCRX | CYH |
|---|---|---|
| Founded | 2006 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 410.5M |
| IPO Year | 2011 | 1991 |
Fundamental Metrics
Financial Performance| Metric | PCRX | CYH |
|---|---|---|
| Price | $26.58 | $3.24 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 7 |
| Target Price | ★ $32.86 | $3.73 |
| AVG Volume (30 Days) | 761.2K | ★ 2.0M |
| Earning Date | 11-06-2025 | 10-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.47 | ★ 2.47 |
| Revenue | $716,791,000.00 | ★ $12,644,000,000.00 |
| Revenue This Year | $6.24 | $0.04 |
| Revenue Next Year | $9.53 | $0.86 |
| P/E Ratio | $55.55 | ★ $1.32 |
| Revenue Growth | ★ 3.14 | 0.74 |
| 52 Week Low | $18.17 | $2.24 |
| 52 Week High | $27.64 | $4.47 |
Technical Indicators
Market Signals| Indicator | PCRX | CYH |
|---|---|---|
| Relative Strength Index (RSI) | 69.80 | 43.55 |
| Support Level | $25.17 | $3.17 |
| Resistance Level | $27.16 | $3.74 |
| Average True Range (ATR) | 0.98 | 0.18 |
| MACD | 0.25 | -0.03 |
| Stochastic Oscillator | 85.16 | 9.29 |
Price Performance
Historical ComparisonAbout PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.